Yuji Kasuya

This inventor holds 23 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Innovations. Top assignees: Daiichi Sankyo Company, Limited, Ngk Spark Plug Company, Limited, National Institutes of Biomedical Innovation, Health and Nutrition. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuji Kasuya. Retrieved from https://idiyas.com/inventor/yuji-kasuya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 5)

% Patents Active = 91.3

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 20)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 149(Granted Patents)

Location History:

Nagoya, JP (2014)
Sumida-ku, JP (2019 - 2020)
Tokyo, JP (2010 - 2023)

Company Filing History:

18 out of 462

Daiichi Sankyo Company, Limited

patents

3 out of 2,606

Ngk Spark Plug Company, Limited

patents

2 out of 23

National Institutes of Biomedical Innovation, Health and Nutrition

patents

4. 1 out of 613

Sankyo Company, Limited

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugate

Anti-HER2 Antibody

Sustained-Release

Cationic Lipid

Oligonucleotide

Pharmaceutical Composition

Eye Disease Treatment

Cancer Therapy

Linker Technology

Polymeric Modifiers

Spark Plug

Immunopotentiating Activity

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12186310 - Antibody-drug conjugate (2025-01-07),

2. 11795236 - Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-10-24),

3. 11633493 - Antibody-drug conjugate (2023-04-25),

4. 11584800 - Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-02-21),

5. 11185594 - (Anti-HER2 antibody)-drug conjugate (2021-11-30),

6. 11015202 - Complex containing oligonucleotide having immunopotentiating activity and use thereof (2021-05-25),

7. 10973924 - Antibody-drug conjugate (2021-04-13),

8. 10808006 - Sustained-release pharmaceutical composition for treatment and prevention of eye disease (2020-10-20),

9. 10731159 - Cationic lipid (2020-08-04),

10. 10729782 - Antibody-drug conjugate produced by binding through linker having hydrophilic structure (2020-08-04),

11. 10533176 - Cationic lipid (2020-01-14),

12. 10208082 - Sustained-release pharmaceutical composition for treatment and prevention of eye disease (2019-02-19),

13. 10202606 - Complex containing oligonucleotide having immunopotentiating activity and use thereof (2019-02-12),

14. 10195288 - Antibody-drug conjugate (2019-02-05),

15. 10155821 - Anti-HER2 antibody-drug conjugate (2018-12-18),

Title: Yuji Kasuya - Innovative Inventor from Tokyo

Introduction: Yuji Kasuya is a renowned inventor hailing from Tokyo, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Yuji Kasuya holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the innovation industry, Yuji Kasuya has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized the way we interact with technology.

Collaborations: Throughout his career, Yuji Kasuya has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Yuji Kasuya's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology, inspiring the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.